Podcast 4: Blockbuster Watch for 2020: New Market Entrants

What are the new blockbuster medicines to watch? In this podcast we feature an article that examines the eleven medicines projected to enter the market in 2020 and achieve blockbuster…

Podcast 3: Orphan Drugs: Bearing Revenue Gains or Not?

Over the past several years, orphan drugs have accounted for more than 40% of new drug approvals by the FDA.  In this podcast, we showcase an article that explores whether…

Podcast 2: Emerging Biopharma Companies: Tracking Their Contribution to Innovation

To what extent do emerging pharma companies contribute to the pharmaceutical industry’s pipeline and new product growth? In this podcast, we showcase an article examining a recent report by IQVIA…

Podcast 1: 20-20 Insights and Outlook for the CDMO Market

The conditions are favorable for another strong year of performance for CDMOs. In this podcast, we showcase an article written by Jim Miller, Consultant and Content Advisor at DCAT, that…